This is the authors' abstract. We don't add key points for this paper.
The title complex, [Zn(2)(C(13)H(19)N(2)O)(2)Cl(2)].2C(3)H(6)O, resides on a crystallographic inversion center. The two Zn(II) centers bridged by the phenoxo groups are in pentacoordinated distorted square-pyramidal coordination environments with an intramolecular Zn...Zn distance of 3.175 (3) A. The mesocyclic ligand takes a boat-chair conformation and an H atom from the 1,5-diazacyclooctane ring effectively blocks the axial coordination site opposite the Cl ligand to form the ZnN(2)O(2)Cl geometry. The crystal structure is stabilized by a N-H...O hydrogen bond between the amino group and an acetone molecule.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: